These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14400985)

  • 21. [THE EFFECT OF SUBCUTANEOUSLY ADMINISTERED SUPRASTIN ON ASCITES TUMOR STRAINS IN MICE].
    HONTI G; PUTNOKY G
    Z Gesamte Inn Med; 1963 Sep; 18():801-3. PubMed ID: 14095005
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of the alpha globulin fraction on the survival time of C3H mice (C3H/Sumice and C3H/VUFB) with a solid Gardner lymphosarcoma.
    Motycka K; Bednarík T; Balcarová A
    Folia Biol (Praha); 1980; 26(5):359-65. PubMed ID: 6160062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [NAD DEGRADATION AND SYNTHESIS OF LYMPHOSARCOMA ASCITES CELLS AFTER ROENTGEN IRRADIATION].
    ALTENBRUNN HJ; STEENBECK L; SCHLEICHER H; EHRHARDT E; SCHMAGLOWSKI S
    Radiobiol Radiother (Berl); 1964; 5():495-500. PubMed ID: 14294086
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppression of antibody-sensitized tumor cells by macrophages: insufficient supply or activation of macrophages within large tumors.
    Johnson RJ; Siliciano RF; Shin HS
    J Immunol; 1979 Feb; 122(2):379-82. PubMed ID: 581674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to 9-beta-D-arabinofuranosyladenine in murine tumor cells.
    LePage GA
    Cancer Res; 1978 Aug; 38(8):2314-6. PubMed ID: 580902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dependence of tumourous infiltration of spleen cells of C3H mice on the growth of subcutaneously transplanted Gardner lymphosarcoma, using different numbers of cells (author's transl)].
    Motycka K; Balcarová A; Jandová A; Stĕrba O
    Sb Lek; 1980 Oct; 82(10):322-7. PubMed ID: 6893635
    [No Abstract]   [Full Text] [Related]  

  • 27. [STUDY OF VARIOUS SPONTANEOUS TUMORS OBSERVED IN XLII MICE].
    GOSSE C; DECHAMBRE RP; GERARD-MARCHANT R; LACOUR F
    Rev Fr Etud Clin Biol; 1964; 9():632-6. PubMed ID: 14187799
    [No Abstract]   [Full Text] [Related]  

  • 28. Sulfonylureas: a new class of cancer chemotherapeutic agents.
    Mohamadi F; Spees MM; Grindey GB
    J Med Chem; 1992 Aug; 35(16):3012-6. PubMed ID: 1501228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lymphosarcomatous milky ascites].
    BERGERON A; DALBIGNAT Y
    Gaz Med Fr; 1952 Sep; 59(17):1029-31. PubMed ID: 13010444
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytokinetic analysis at various ages of an ascites tumor after radiation.
    Siracká E; Pappová N
    Tumori; 1978 Oct; 64(5):463-70. PubMed ID: 581811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mesenteric reticulo-lymphosarcoma. Chyliform ascites. Treatment by telecobalt and colloidal chromium radiophosphate].
    GUERIN RA
    J Radiol Electrol Med Nucl; 1962 Oct; 43():669-71. PubMed ID: 13951098
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON THE EFFECT OF THE INTRAPERITONEAL ADMINISTRATION OF SUPRASTIN SOLUTION ON ASCITES TUMOR STRAINS IN MICE].
    HONTI G; PUTNOKY G
    Z Gesamte Inn Med; 1963 Aug; 18():692-4. PubMed ID: 14085698
    [No Abstract]   [Full Text] [Related]  

  • 33. A cytological evaluation of combined therapy in the 6C3HED lymphosarcoma. I. -SH-containing analogs in combination with nitrogen mustard and mapharsen.
    ROOSA RA; DELAMATER ED
    Cancer Res; 1960 Dec; 20():1543-54. PubMed ID: 13743185
    [No Abstract]   [Full Text] [Related]  

  • 34. Theta antigen on a murine lymphosarcoma.
    Merino F; Abeyounis CJ; Milgrom F
    Transplant Proc; 1973 Mar; 5(1):975-6. PubMed ID: 4540469
    [No Abstract]   [Full Text] [Related]  

  • 35. [Milky ascites and retroperitoneal tumor].
    PARAF A; LEWI J
    Rev Med Chir Mal Foie; 1955; 30(3):57-69. PubMed ID: 13290498
    [No Abstract]   [Full Text] [Related]  

  • 36. LDH-viral activity transferred with cell surface antigens of Gardner lymphosarcoma cells. Short communication.
    Motycka K; Bostík J; Slavík K; Bures L; Pezlarová J; Jandová A
    Z Versuchstierkd; 1984; 26(5):209-10. PubMed ID: 6549095
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of Alexan on the number of plaque-forming cells collected from the spleen of C3H mice with Gardner's lymphosarcoma or infected with LDH viruses].
    Motycka K; Herzog P; Chudomel V; Bostík J; Jandová A; Pezlarová J; Stĕpánová I
    Sb Lek; 1984 Sep; 86(8-9):251-8. PubMed ID: 6548832
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunity to the 6C3HED ascites tumor following treatment of tumor-bearing mice with Escherichia coli L-asparaginase.
    Prager MD; Roberts J; Bachynsky N
    J Immunol; 1967 May; 98(5):1045-52. PubMed ID: 5337669
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in metabolism, food and water intake of C3H mice following transplantation of Gardner lymphosarcoma (LSG).
    Bostík J; Vybíral S; Spundová M
    Physiol Bohemoslov; 1988; 37(4):325-32. PubMed ID: 2973618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
    Motycka K; Chudomel V; Bednár M; Bostík J
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):413-9. PubMed ID: 6549500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.